TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Compliance rate of fasting blood glucose (FBG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total score of the 'My Opinion on Insulin' scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: better alcohol outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean analgesic requirement in terms of fentanyl equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elimination of filling remnants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate for prediabetes or T2DM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of composite end-point
Endpoint domain: Mortality/survival
Primary endpoint: body dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in combustible and smokeless tobacco use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak RNFLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of 1 vaccine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful rate of painless gastroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED50 of nalbuphine combined with propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED95 of nalbuphine combined with propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total allogeneic blood products at 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Surgical Site Infection Rate (SSIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Threshold shift at 11.2 kHz
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sitting balance and trunk stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with poor adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants with excellent adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: annual moderate-to-severe exacerbation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major relapse-free survival
Endpoint domain: Mortality/survival
Primary endpoint: proportion of ROSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of happiness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: health effects of NNDDs compared with combustible cigarettes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition of facial emotions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-management abilities
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: engagement in meaningful activities
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Total Pain Relief scores (TOTPAR0–120 min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year probability of death
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of environmental risk-reduction practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: periprocedural myocardial infarctions
Endpoint domain: Adverse events/effects
Primary endpoint: safety and effectiveness of doxorubicin nano-drug delivery preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life at End of Life (QOL-EOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Effective response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reductions in depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total PAS score reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Amount of fentanyl administered via IV PCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reward positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation rate among physicians
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Size of the IPFP preserved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical Angle (CVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder Angle (SA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression (GDS-15 score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dispositional Optimism (LOT-R score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Median cfDNA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic intrasinus bone gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intimal hyperplasia area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major cardiac or cerebrovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Oxford Knee Score at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported improvement (transition)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cost-effectiveness (measured using quality-adjusted life-years)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 10-year ARR cumulative incidence
Endpoint domain: Mortality/survival
Primary endpoint: Lymphedema rate
Endpoint domain: Adverse events/effects
Primary endpoint: Quality-of-life scales
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sleep quality score in infants
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Postpartum anxiety score of mothers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ulcer-free period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Physical assistance required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prediction error of fetal weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of fetal weight prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical role domain improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VEGFA mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VEGFA/PEDF mRNA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative proportion of children without significant postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upper extremity motor improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary kidney outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: QOLRAD score changes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Success of procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications (infection, hematoma, neuronal injury)
Endpoint domain: Adverse events/effects
Primary endpoint: Complete resolution of RPOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of vaginal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AEFI detection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum pupil diameter after dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Maintenance of Wakefulness Test (MWT20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neointimal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mean serum hs-CRP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean serum levels of VCAM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of ICAM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in patients' knowledge, attitude, and hygiene
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increase in cervical and shoulder angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of the pectoralis minor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: strength of the scapular muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total reconstruction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systemic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy content of lunch orders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Saturated fat content of lunch orders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Odds of having everyday items purchased
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful completion of salpingectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute difference in AVQI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute difference in ABI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate in nursing homes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Posttreatment DSM diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HDL-mediated eNOS-Ser1177 phosphorylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HDL-associated Pon1 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of thiobarbituric acid-reactive substances (TBARS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BARC type 2, 3, or 5 bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: mobilization-related safety events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence rate of toxic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Correct catheter placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Systemic oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AT pO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SM pO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG high-alpha activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DD values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suturing skills checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Rating Scale (GRS) assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychopathological features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: macular VD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TOI changes in biceps muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TOI changes in masseter muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum Cr levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: survival at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: plasma concentrations of proteins involved in inflammation and proteolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: echocardiographic measures of diastolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median pain-free survival
Endpoint domain: Mortality/survival
Primary endpoint: antidepressant effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone surface area increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Driving After Cannabis Use (DACU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risky Driving Behavior Change (RWCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean platelet number increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Behavioral adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of colds experienced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of recurring colds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Practice of physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy for physical activity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: relative oral bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delay in Tmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prolongation in MRT0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain/Discomfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Bacterial counts on abutments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD3+ level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postoperative morphine dose
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of postoperative itching, nausea, and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Composite z-score of blood pressure, BMI, and cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete reconfiguration of order sets
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient recruitment target met
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: survival benefit of RT
Endpoint domain: Mortality/survival
Primary endpoint: Attendance at follow-up appointments
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: reduction in vasopressor dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in plasma H2S level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-treatment culture negativity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in students' anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enhancement of well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence rates of lifestyle diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence rates of lifestyle diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total number of health care contacts
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: NT-proCNP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bioactive CNP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total area under the curve (tAUC)15‐270 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radboud Oral Motor Inventory for Parkinson's Disease–Saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean concentrations of anti-pertussis toxin IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: average maximum intravertebral pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cement distribution volume (CMV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cement leakage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall treatment satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: preference for treatment via PDS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean score of access and coronal cavity preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of atrial diameter from baseline to 24 weeks after RFCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reading the Mind in the Eyes Test (RMET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparation time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Wound closure time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost savings
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: mean infarct size percentage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severe Acute Kidney Injury (severe AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of patients with grade 1 peristalsis post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: disease-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: HIV-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Improvements in verbal learning and memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvements in attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvements in cognitive flexibility and processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Preference to teach using flipped classroom methodology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Professional satisfaction from teaching
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean MCV values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of reactive bradycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trust in provider
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: team-based cancer care knowledge scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scheduling a PCP follow-up visit
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: communication with PCP about provider roles
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: weightlifting ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RPE values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total maximal chorea score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of decision to drive drunk (DD)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Food responsiveness in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with microplanning processes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEB rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total clinical chair time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total post-surgery procedure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cavitary lesions on X-ray
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's non-sedentary time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regrowth scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AA specific trichoscopic signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes